COST Actions

The European Cooperation in Science and Technology (COST) is a funding organisation for the creation of research networks, called COST Actions. These networks offer an open space for collaboration among scientists across Europe (and beyond) and thereby give impetus to research advancements and innovation.COST Action is a network dedicated to scientific collaboration, complementing national research funds. A COST Action is organised by a range of networking tools, such as meetings, conferences, workshops, short-term scientific missions, training schools, publications and dissemination activities. Funding covers the cost of COST Action networking tools. The average COST Action support is EUR 130,000 per annum for participation by typically 25 COST Members.


The workers of the Laboratory of Biotransformation are involved in the following COST Actions:

A Comprehensive Network Against Brain Cancer (Net4Brain)

Towards zer0 Pesticide AGRIculture : European Network for sustainability (T0P-AGRI-Network)

European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (EURESTOP)

Modelling immunotherapy response and toxicity in cancer (IMMUNO-model)

Identification of biological markers for prevention and translational medicine in pancreatic cancer (TRANSPAN)

One Health drugs against parasitic vector borne diseases in Europe and beyond (OneHealthdrugs)

Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases (BenBedPhar)

Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (Mye-InfoBank)


Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes (GLYCONanoPROBES)

Innovation with Glycans: new frontiers from synthesis to new biological targets (INNOGLY)

Cancer nanomedicine – from the bench to the bedside (Nano2Clinic)


Past Actions

Identifying Biomarkers Through Translational Research for Prevention and Stratification of Colorectal Cancer (TRANSCOLONCAN)

          New diagnostic and therapeutic tools against multidrug resistant tumors (STRATAGEM)

Combatting anthelmintic resistance in ruminants

Realising the therapeutic potential of novel cardioprotective therapies

          European Network on Understanding Gastrointestinal Absorption-related Processes (UNGAP)

Biomaterials and advanced physical techniques for regenerative cardiology and neurology (BIONECA)

          Personalized nutrition in aging society: redox control of major age-related diseases (NutRedOx)

European network to advance carotenoid research and applications in agro-food and health (EUROCAROTEN)

Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)

          Challenging organic syntheses inspired by nature – from natural products chemistry to drug discovery

          Interindividual variation in response to consumption of plant food bioactives and determinants involved (POSITIVe)

          Targeted chemotherapy towards diseases caused by endoparasites

          Systems Biocatalysis


          Multivalent Glycosystems for Nanoscience – MultiGlycoNano

          Biological oxidation reactions – mechanisms and design of new catalysts

          Chemistry of non-enzymatic protein modification – modulation of protein structure and function

          Chemical Biology with Natural Products

          Cascade Chemoenzymatic Processes – New Synergies Between Chemistry and Biochemistry

          Inhibitors of angiogenesis: design, synthesis and biological exploitation (ANGIOKEM)

          Multivalent ligands for cholera toxin inhibition and sensing

          Stereoselective synthesis of piperidine derivatives as useful synthons for target-  oriented and diversity-oriented synthesis of bioactive natural products and analogues

          Nitrile- and amide-hydrolyzing enzymes as tools in organic chemistry

          Novel methods for enzymatic synthesis of bioactive glycosides